← FDA Drug Approvals (Drugs@FDA)

OGIVRI

BLA · Biologics License Application · Sponsor: MYLAN GMBH · Approved 2017-12-01

Drug application

FDA Application #

BLA761074

Application type

Biologics License Application

Brand name

OGIVRI

Generic name

TRASTUZUMAB-DKST

Active ingredients

TRASTUZUMAB-DKST

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

MYLAN GMBH

Manufacturer

Biocon Biologics Inc.

First approval

2017-12-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown